Over 600 Imperial medical students sign up to support with COVID-19 vaccinations
As COVID-19 vaccine efforts step up across London, Imperial medical students are amongst the many volunteers who are helping out.
Imperial’s Covid outbreak tool projects vaccine impact around world
Imperial’s coronavirus outbreak tool has been updated to project the impact of vaccine programmes in all countries.
President Alice Gast hosts panel discussion with three top COVID-19 scientists
Hosted by President Alice Gast, three leading scientists discuss vaccines, immunity and Imperial’s contribution to the fight against the deadly virus.
Exposure to misinformation could make people refuse a COVID-19 vaccine
Exposure to online misinformation about COVID-19 vaccines could reduce vaccine uptake, threatening the goal of herd immunity.
3
Video
COVID-19 reflections: the lessons learnt from the pandemic
Imperial researchers reflect on the lessons they will take away from the pandemic.
COVID Vaccine Trial Participants at Imperial CRF share their Experience
When the pandemic hit, nearly all the resources at the Imperial Clinical Research Facility (CRF) were directed to help tackle COVID-19.
Vaccines prevented 37 million deaths in LMICs in the last 20 years
Vaccine programmes in low- and middle-income countries have prevented 37 million deaths in the last 20 years alone – 36 million in children under 5.
Imperial vaccine tech to target COVID mutations and booster doses
Imperial is focusing its RNA vaccine technology to target SARS-CoV-2 mutations, boosters and thermostability rather than an immediate efficacy trial.
Vaccines may not signal immediate end to epidemic, researchers say
The vaccine rollout may not signal an immediate end to the Covid-19 epidemic, according to latest modeling from Imperial’s Covid-19 Response Team.
Vaccine collaboration could overcome cold chain issues for RNA-based vaccines
Imperial vaccine researchers are collaborating with industry partners to develop RNA vaccines stable at temperatures up to 40C.
